NKF KDOQI GUIDELINES

KDOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients

Tables
Figures
Acronyms and abbreviations
Work group members
KDOQI advisory board members
Foreword
Overview of epidemiology of cardiovascular disease
Overview of epidemiology of cardiovascular disease in children

Section I. Guidelines on evaluation and management of cardiovascular diseases

Guideline 1: Evaluation of Cardiovascular Disease in Adult and Pediatric Patients
Guideline 2: Coronary Artery Disease
Guideline 3: Acute Coronary Syndromes
Guideline 4: Chronic Coronary Artery Disease
Guideline 5: Valvular Heart Disease
Guideline 6: Cardiomyopathy (Systolic or Diastolic Dysfunction)
Guideline 7: Dysrhythmia
Guideline 8: External Defibrillation
Guideline 9: Cerebrovascular Disease
Guideline 10: Peripheral Vascular Disease

Section II. Guidelines on management of cardiovascular risk factors

Guideline 11: Diabetes
Guideline 12: Blood Pressure
Guideline 13: Dyslipidemia
Guideline 14: Smoking, Physical Activity, and Psychological Factors
Guideline 15: Anemia
Guideline 16: Arterial Stiffness, Vascular and Valvular Calcification, Calcium, Phosphorus and PTH

Section III. State of the science: novel and controversial topics in cardiovascular diseases

Intradialytic Hypotension

Biomarkers

Troponin
Inflammation
Oxidative Stress

Nutritional and Metabolic Factors

Body Weight and Management
Omega-3 Fatty Acids
Homocysteine
Lipoprotein(a) and Apolipoprotein(a) Polymorphism
Malnutrition

Risk Stratification

Overview of Risk Stratification
Family History and Genetics
Menopause
Preventive Foot Care in Diabetes
Aspirin

Methods for review of article
Work group biographies
Acknowledgment
References
Disclaimer